Cargando…

Diagnostic utility and performance of rapid antigen test in SARS CoV- 2 in symptomatic and asymptomatic patients during the second pandemic wave in Kashmir, North India

PURPOSE: Real time reverse transcriptase PCR (rRT PCR) although gold standard test for the diagnosis of SARS CoV-2, carries disadvantages of a sophisticated set up, long time to results and centralized services. The rapid antigen tests (RAT) can be used as a primary screening tool with the advantage...

Descripción completa

Detalles Bibliográficos
Autores principales: Farhana, Anjum, Zahoor, Danish, Wani, Sanam, Khan, Reyaz Ahmed, Nasir, Reyaz, Kanth, Farhath
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Indian Association of Medical Microbiologists. Published by Elsevier B.V. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9249411/
https://www.ncbi.nlm.nih.gov/pubmed/35787334
http://dx.doi.org/10.1016/j.ijmmb.2022.06.007
_version_ 1784739575159062528
author Farhana, Anjum
Zahoor, Danish
Wani, Sanam
Khan, Reyaz Ahmed
Nasir, Reyaz
Kanth, Farhath
author_facet Farhana, Anjum
Zahoor, Danish
Wani, Sanam
Khan, Reyaz Ahmed
Nasir, Reyaz
Kanth, Farhath
author_sort Farhana, Anjum
collection PubMed
description PURPOSE: Real time reverse transcriptase PCR (rRT PCR) although gold standard test for the diagnosis of SARS CoV-2, carries disadvantages of a sophisticated set up, long time to results and centralized services. The rapid antigen tests (RAT) can be used as a primary screening tool with the advantages of rapid turnaround time and ease of use. The study was conducted to determine the performance of rapid antigen test (standard Q COVID 19 Ag) in comparison to rRT PCR in symptomatic patients and asymptomatic contacts and asymptomatic patients with no apparent contact history. METHODS: Nasopharyngeal swabs taken in duplicate from 1034 patients were collected over a 5 months period. These included 248 (23.98%) symptomatic, 386 (37.34%) asymptomatic contacts and 400 (38.68%) asymptomatic subjects who were routinely screened in pre-operative period, as a prerequisite for travel, or pregnant females. Both rRT PCR and RAT were performed as per manufacturers’ instructions. Performance of test in different subgroups of patients was evaluated. Performance of RAT test on basis of duration of illness and Ct values was also analyzed. RESULTS: In this study, 445 (43.04%) were rRT PCR positive, out of which 374 samples were RAT positive as well. 31 samples were RAT positive but PCR negative. The sensitivity, specificity, PPV and NPV of the rapid antigen test was 84.04%, 94.74%, 92.35% and 88.71% respectively. The negative predictive value of the test in asymptomatic patients without any significant contact history was 97.07%. CONCLUSIONS: This study recommends the use of the antigen test as a method of diagnosis for SARS CoV-2. However a negative result with RAT in suspected patients and their contacts should be viewed with caution. This study also finds the utility of using RAT test in the community settings as a screening test in schools, colleges and mass gatherings.
format Online
Article
Text
id pubmed-9249411
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Indian Association of Medical Microbiologists. Published by Elsevier B.V.
record_format MEDLINE/PubMed
spelling pubmed-92494112022-07-05 Diagnostic utility and performance of rapid antigen test in SARS CoV- 2 in symptomatic and asymptomatic patients during the second pandemic wave in Kashmir, North India Farhana, Anjum Zahoor, Danish Wani, Sanam Khan, Reyaz Ahmed Nasir, Reyaz Kanth, Farhath Indian J Med Microbiol Original Research Article PURPOSE: Real time reverse transcriptase PCR (rRT PCR) although gold standard test for the diagnosis of SARS CoV-2, carries disadvantages of a sophisticated set up, long time to results and centralized services. The rapid antigen tests (RAT) can be used as a primary screening tool with the advantages of rapid turnaround time and ease of use. The study was conducted to determine the performance of rapid antigen test (standard Q COVID 19 Ag) in comparison to rRT PCR in symptomatic patients and asymptomatic contacts and asymptomatic patients with no apparent contact history. METHODS: Nasopharyngeal swabs taken in duplicate from 1034 patients were collected over a 5 months period. These included 248 (23.98%) symptomatic, 386 (37.34%) asymptomatic contacts and 400 (38.68%) asymptomatic subjects who were routinely screened in pre-operative period, as a prerequisite for travel, or pregnant females. Both rRT PCR and RAT were performed as per manufacturers’ instructions. Performance of test in different subgroups of patients was evaluated. Performance of RAT test on basis of duration of illness and Ct values was also analyzed. RESULTS: In this study, 445 (43.04%) were rRT PCR positive, out of which 374 samples were RAT positive as well. 31 samples were RAT positive but PCR negative. The sensitivity, specificity, PPV and NPV of the rapid antigen test was 84.04%, 94.74%, 92.35% and 88.71% respectively. The negative predictive value of the test in asymptomatic patients without any significant contact history was 97.07%. CONCLUSIONS: This study recommends the use of the antigen test as a method of diagnosis for SARS CoV-2. However a negative result with RAT in suspected patients and their contacts should be viewed with caution. This study also finds the utility of using RAT test in the community settings as a screening test in schools, colleges and mass gatherings. Indian Association of Medical Microbiologists. Published by Elsevier B.V. 2022 2022-07-02 /pmc/articles/PMC9249411/ /pubmed/35787334 http://dx.doi.org/10.1016/j.ijmmb.2022.06.007 Text en © 2022 Indian Association of Medical Microbiologists. Published by Elsevier B.V. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Original Research Article
Farhana, Anjum
Zahoor, Danish
Wani, Sanam
Khan, Reyaz Ahmed
Nasir, Reyaz
Kanth, Farhath
Diagnostic utility and performance of rapid antigen test in SARS CoV- 2 in symptomatic and asymptomatic patients during the second pandemic wave in Kashmir, North India
title Diagnostic utility and performance of rapid antigen test in SARS CoV- 2 in symptomatic and asymptomatic patients during the second pandemic wave in Kashmir, North India
title_full Diagnostic utility and performance of rapid antigen test in SARS CoV- 2 in symptomatic and asymptomatic patients during the second pandemic wave in Kashmir, North India
title_fullStr Diagnostic utility and performance of rapid antigen test in SARS CoV- 2 in symptomatic and asymptomatic patients during the second pandemic wave in Kashmir, North India
title_full_unstemmed Diagnostic utility and performance of rapid antigen test in SARS CoV- 2 in symptomatic and asymptomatic patients during the second pandemic wave in Kashmir, North India
title_short Diagnostic utility and performance of rapid antigen test in SARS CoV- 2 in symptomatic and asymptomatic patients during the second pandemic wave in Kashmir, North India
title_sort diagnostic utility and performance of rapid antigen test in sars cov- 2 in symptomatic and asymptomatic patients during the second pandemic wave in kashmir, north india
topic Original Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9249411/
https://www.ncbi.nlm.nih.gov/pubmed/35787334
http://dx.doi.org/10.1016/j.ijmmb.2022.06.007
work_keys_str_mv AT farhanaanjum diagnosticutilityandperformanceofrapidantigentestinsarscov2insymptomaticandasymptomaticpatientsduringthesecondpandemicwaveinkashmirnorthindia
AT zahoordanish diagnosticutilityandperformanceofrapidantigentestinsarscov2insymptomaticandasymptomaticpatientsduringthesecondpandemicwaveinkashmirnorthindia
AT wanisanam diagnosticutilityandperformanceofrapidantigentestinsarscov2insymptomaticandasymptomaticpatientsduringthesecondpandemicwaveinkashmirnorthindia
AT khanreyazahmed diagnosticutilityandperformanceofrapidantigentestinsarscov2insymptomaticandasymptomaticpatientsduringthesecondpandemicwaveinkashmirnorthindia
AT nasirreyaz diagnosticutilityandperformanceofrapidantigentestinsarscov2insymptomaticandasymptomaticpatientsduringthesecondpandemicwaveinkashmirnorthindia
AT kanthfarhath diagnosticutilityandperformanceofrapidantigentestinsarscov2insymptomaticandasymptomaticpatientsduringthesecondpandemicwaveinkashmirnorthindia